SCHEMBL26871014

SCHEMBL26871014

CCC(c1cc(Cl)n2nccc2n1)C1CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE10A Q9Y233 1/20 0.51
▸ CCNT1 O60563 17/20 0.42
▸ CDK9 P50750 17/20 0.42
▸ CDK4 P11802 2/20 0.42
▸ CCND1 P24385 2/20 0.42
▸ CDK7 P50613 2/20 0.42
▸ CCNH P51946 2/20 0.42
▸ CCNK O75909 1/20 0.42
▸ CDK14 O94921 1/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CDK1 P06493 1/20 0.42
▸ CCNA2 P20248 1/20 0.42
▸ CCNC P24863 1/20 0.42
▸ CCNE1 P24864 1/20 0.42
▸ CDK2 P24941 1/20 0.42
▸ CCNA1 P78396 1/20 0.42
▸ CDK3 Q00526 1/20 0.42
▸ CDK6 Q00534 1/20 0.42
▸ CDK5 Q00535 1/20 0.42
▸ CDK17 Q00537 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14545874 0.95 PDE10A (0.49) PDE10ACCNT1CDK9CDK4CCND1
SCHEMBL26871164 0.86 PDE10A (0.44) PDE10ACCNT1CDK9CDK4CCND1
SCHEMBL26872363 0.84 CCNT1 (0.45) CCNT1CDK9CDK4CCND1CDK7
SCHEMBL26868185 0.84 CCNT1 (0.45) CCNT1CDK9CDK4CCND1CDK7
SCHEMBL26872289 0.84 CCNT1 (0.45) CCNT1CDK9CDK4CCND1CDK7
SCHEMBL26870870 0.82 PDE10A (0.51) PDE10ACCNT1CDK9CDK4CCND1
SCHEMBL26872049 0.82 CCNT1 (0.51) CCNT1CDK9CDK4CCND1CDK7
SCHEMBL26871365 0.82 PDE10A (0.54) PDE10ACCNT1CDK9CDK4CCND1
SCHEMBL14043130 0.81 CCNT1 (0.48) CCNT1CDK9CDK4CCND1CDK7
SCHEMBL21877657 0.80 PDE10A (0.56) PDE10ACCNT1CDK9CDK4CCND1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4282868-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINE-7-AMINE DERIVATIVE, AND COMPOSITIONS AND MEDICAL USE THEREOF Shanghai Haiyan Pharmaceutical Technology Co., Ltd (CN) 2023-11-29 — — EP disclosed
Send feedback